Will allow firm to sell biocidal products for disinfectant sprays in European medical market
Biocidal technology company Byotrol has won a key authorisation allowing it to sell disinfectant products into the European medical market for the first time.
The company has been awarded CE marking status, meaning it can now supply its biocidal products for use in disinfectant sprays, wipes and foams.
The CE Mark indicates that products comply with the relevant requirements of European health, safety and environmental protection legislation.
“This represents a major milestone for the Company and allows our technology to be sold into the healthcare industry on a pan European basis,” said Byotrol deputy chairman Stephen Falder. “As well as opening up business opportunities in Europe, it also means we can sell to UK based companies with European operations that want to deploy a single hygiene regime across their business.”
Byotrol has developed patented technology for killing dangerous microbes such as MRSA, Legionella, Listeria and E.coli, as well as ordinary household germs. Uniquely, it provides continuing protection once applied and does not harm organisms larger than microbes.
The new approval also allows the use of the CE Mark by third party suppliers using Byotrol as an ingredient brand in their own products - removing the need for separate additional clearance, and further increasing the size of the potential market.